Pages that link to "Q35863422"
Jump to navigation
Jump to search
The following pages link to Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies (Q35863422):
Displaying 50 items.
- Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline (Q22242395) (← links)
- Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014 (Q28073680) (← links)
- Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease (Q28085513) (← links)
- Rat butyrylcholinesterase-catalysed hydrolysis of N-alkyl homologues of benzoylcholine (Q28583696) (← links)
- Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity (Q28586552) (← links)
- Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model (Q30650444) (← links)
- Structural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM study (Q33697892) (← links)
- Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data (Q34032505) (← links)
- MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats (Q34591272) (← links)
- MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake (Q34591584) (← links)
- Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study (Q35203115) (← links)
- Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages. (Q35659990) (← links)
- A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia (Q36118555) (← links)
- Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects (Q36135045) (← links)
- Evaluation and management of the non-motor features of Parkinson's disease (Q36443721) (← links)
- Divergent brain functional network alterations in dementia with Lewy bodies and Alzheimer's disease (Q36444633) (← links)
- Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options (Q36492310) (← links)
- Management of Parkinson's disease dementia : practical considerations (Q36635473) (← links)
- Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis (Q36745127) (← links)
- Rivastigmine in Parkinson's disease dementia: profile report (Q36760303) (← links)
- Intervening in the neuropsychiatric features of Parkinson's disease (Q36847266) (← links)
- Phenserine (Q36861622) (← links)
- Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease (Q37039444) (← links)
- Treatment of dementia associated with Parkinson's disease (Q37082148) (← links)
- Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's disease. (Q37145718) (← links)
- Cognitive Impairment Associated with Parkinson's Disease: Role of Mitochondria (Q37168743) (← links)
- Clinical features of dementia with lewy bodies in 35 Chinese patients (Q37497482) (← links)
- Treatment of dementia with lewy bodies (Q37552865) (← links)
- Rivastigmine in Parkinson's disease dementia (Q37556550) (← links)
- Treatment of dementia with Lewy bodies and Parkinson's disease dementia (Q37942219) (← links)
- Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management. (Q38107409) (← links)
- Cognitive impairment and dementia in Parkinson's disease: practical issues and management. (Q38206499) (← links)
- Dementia in older people: an update (Q38264846) (← links)
- A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders. (Q38851564) (← links)
- Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline (Q38961546) (← links)
- Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015). (Q39038234) (← links)
- Comprehensive treatment of dementia with Lewy bodies (Q41317541) (← links)
- Insular atrophy at the prodromal stage of dementia with Lewy bodies: a VBM DARTEL study. (Q41534288) (← links)
- Comparative Studies on Behavioral, Cognitive and Biomolecular Profiling of ICR, C57BL/6 and Its Sub-Strains Suitable for Scopolamine-Induced Amnesic Models. (Q41573979) (← links)
- Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain (Q42477235) (← links)
- Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis. (Q42610667) (← links)
- Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial (Q42930136) (← links)
- A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. (Q44790322) (← links)
- Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients (Q44908766) (← links)
- Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson's disease. (Q46001712) (← links)
- A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. (Q46704118) (← links)
- Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study (Q48189129) (← links)
- Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study (Q48240563) (← links)
- Covariance 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: utility in differential diagnosis (Q48371182) (← links)
- Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease? (Q48445688) (← links)